av/varex-imaging--big.svg

COM:VAREXIMAGING

Varex Imaging

  • Stock

USD

Last Close

16.51

22/11 21:00

Market Cap

574.64M

Beta: -

Volume Today

1.22M

Avg: -

Company Overview

Metric
Company NameVarex Imaging CorporationQuidelOrtho
SymbolVREX
MSH IDCOM:VAREXIMAGINGCOM:QUIDEL
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryMedical - DevicesMedical Devices and Diagnostics
CountryUSUS
Stage
Employee Count2.30K
Websitevareximaging.comquidel.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap574.64M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue811M
Revenue (LTM)
Revenue (NTM)
Gross Profit256.90M
EBITDA67.20M
Operating Income32.10M
Net Income-47.70M
EPS-1.17
Diluted EPS-1.17
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.32
Operating Profit Margin0.08
EBITDA Margin0.08
Net Profit Margin0.05
Return on Equity0.08
Return on Assets0.04
Return on Capital Employed0.06

Valuation Multiples

Metric
P/E Ratio16.24
P/B Ratio1.38
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.81
EV Multiple5.40

Operational Metrics

Metric
Days Sales Outstanding66.84
Days Payables Outstanding39.16
Days Inventory Outstanding182.02
Operating Cycle248.95
Cash Conversion Cycle203.98
Asset Turnover0.71

Cash Flow Metrics

Metric
Operating Cash Flow108.40M
Free Cash Flow87.70M
Cash Flow to Debt0.26
Operating Cash Flow/Sales0.14
Free Cash Flow Yield0.07

Balance Sheet Metrics

Metric
Cash & Equivalents168.70M
Accounts Receivable9.80M
Inventory264.80M
Goodwill291M
Debt to Capitalization0.45
Debt to Assets0.38
Current Ratio4.04
Quick Ratio2.37

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.02
R&D to Revenue0.09
SG&A to Revenue